AI-generated analysis. Always verify with the original filing.
Outlook Therapeutics, Inc. held its Annual Meeting on March 10, 2026, where stockholders voted on three proposals. The filing reports these matters under Item 5.07 and includes Exhibit 104.
Event Type
Disclosure
Mandatory
Variant
8-K
Submission of Matters to a Vote of Security Holders At the Annual Meeting held on March 10, 2026, the Company’s stockholders voted on three proposals, each of w
Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE